Follow a patient's journey through advanced HCC and make decisions on treatment selection and sequencing in this interactive patient case video presented by Prof. Dr Timon Vandamme.
As you interact and engage with valuable information, challenging questions, and clickable resources, you'll choose your preferred 1st line treatment option for this patient, when to switch to 2nd line treatment, and which 2nd line option to recommend.
- IO based treatments are the first choice for patients with advanced HCC without active auto-immune disease and without liver transplant
- In case of slow progression, continuing IO based treatment should be considered for patients with HCC
- Research is ongoing to determine the best treatment options and sequencing after progression on IO based treatment for patients with HCC